VIDAS Varicella Zoster IgG (VZG) antibody IVD, kit
bioMerieux, Inc. began a recall of VIDAS Varicella Zoster IgG (VZG) antibody IVD, kit on . FDA classified it as Class II and gives the reason as "Two batches of VIDAS Varicella-Zoster IgG (VZG ref 30217) may yield an invalid calibration which may delay the patient's sample result or a valid calibration may lead to a false positive patient result". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.
Recall record
- Recall number
- Z-1107-2020
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- bioMerieux, Inc.
- Product
- VIDAS Varicella Zoster IgG (VZG) antibody IVD, kit
- Product code
- LFY Enzyme Linked Immunoabsorbent Assay, Varicella-Zoster
- Reason for recall
- Two batches of VIDAS Varicella-Zoster IgG (VZG ref 30217) may yield an invalid calibration which may delay the patient's sample result or a valid calibration may lead to a false positive patient result.
- Root cause tag
- manufacturing process
- FDA root cause
- Unknown/Undetermined by firm
- Action
- Users are instructed via customer letter to stop using the VIDAS VZG batches 1007410330 and 1007393380 and destroy the remaining products.
- Quantity in commerce
- 1,218 US units total (726 US, 492 OUS)
- Distribution
- Distributed nationwide and 9 units to Biomerieux Canada.
- Product codes and lots
- US Model 30217-01 Lot 1007410330 and 1007393380
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-1107-2020 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
